Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06627998

Study of the Prevalence of Osteo-metabolic Complications in Patients With Thyroid Cancer

This is a multicenter retrospective observational study aimed to evaluate the prevalence of osteo-metabolic complications in patients with thyroid cancer.

Recruiting

Interested in participating?

Request Info

Key information

About this study

Approximately 150-200 outpatients evaluated in the Endocrinology Unit of the IRCCS San Raffaele Hospital and the Nuclear Medicine Unit of the Spedali Civili of Brescia will be included in the study.

During the follow-up visits, patients who meet the inclusion criteria will be offered inclusion in the study. After signing the informed consent, the patient's anamnestic and clinical (biochemical, radiological, anamnestic) data will be retrospectively collected in an electronic database. Sensitive data will be anonymized.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age ≥ 18 years
  • Histological diagnosis of Thyroid Carcinoma
  • radiological data from chest x-ray in lateral projection in the preoperative evaluation on which the vertebral morphometry
  • Signing of the informed consent

Exclusion criteria

  • Subjects not falling within the previously described criteria are excluded

Treatment and study plan

Diagnostic (chest x-ray /DXA)and clinical data collected for clinical practice

Diagnostic Test

Biochemical, clinical and radiological data performed for clinical practice will be retrospectively collected. Osteoporosis and vertebral fractures will be diagnosed through DXA scan and vertebral morphometry.

Primary outcomes

  1. To estimate the incidence and prevalence of osteoporosis and vertebral fractures in Patients With Thyroid Cancer

    Time frame: 1 year

    To estimate the incidence and prevalence of osteoporosis and vertebral fractures detected through DXA scan and vertebral morphometry. The effects on bone complications of the patients' clinical and biochemical characteristics will be investigated.

Study contacts

Contact information is provided by the study sponsor or research team.

Luigi Di Filippo, medical doctor

CONTACT

[email protected]

0226435062

Sponsors and collaborators

Lead sponsor

IRCCS San Raffaele

Other

Collaborators

  • Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Registry information

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Oct 4, 2024
Registry last updated
Oct 4, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.